Close Menu

This article has been updated to clarify the FDA's request to labs.

NEW YORK – The American Clinical Laboratory Association (ACLA) yesterday issued a letter to the US Food and Drug Administration urging the agency to reconsider its recent actions against laboratories, asking them to change the way they matket pharmacogenetic (PGx) testing and report results.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.

Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.

Washington Post columnist writes that she is skeptical about DNA-based diets.

In PNAS this week: recurrent inactivation of DEPDC5 in gastrointestinal stromal tumors, taxonomic reliability of GenBank sequences, and more.